Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • Log out
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiology, Biomarkers & Prevention
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Null Results in Brief

Dinucleotide Repeat in the Insulin-like Growth Factor-I Gene Is Not Related to Risk of Colorectal Adenoma

Edward Giovannucci, Christopher A. Haiman, Elizabeth A. Platz, Susan E. Hankinson, Michael N. Pollak and David J. Hunter
Edward Giovannucci
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christopher A. Haiman
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elizabeth A. Platz
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Susan E. Hankinson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael N. Pollak
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David J. Hunter
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI:  Published November 2002
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Introduction

IGF-I3 may be associated with bone mineral density in mice (1) and in men with IOM (2) . Rosen et al. (3) examined a polymorphic microsatellite composed of variable length CA repeats 1-kb upstream from the transcription start site of IGF-I among 25 men with IOM. Men with IOM had a significant excess of homozygosity for the most common allele (CA19), and the CA19/19 genotype was associated with lower serum IGF-I compared with other genotypes (129 versus 154 ng/ml; P = 0.03) in normal controls. IGF-I level may also increase risk of colorectal cancer. In the NHS, high plasma IGF-I and low IGFBP-3 concentrations were associated with an elevated risk of colorectal cancer and adenoma (4) . We examined whether this CA repeat predicted risk of colorectal adenoma and plasma IGF-I levels.

Materials and Methods

Cases of colorectal adenoma and controls were drawn from participants in the NHS, a prospective study of United States female registered nurses (4) . From 1989 to 1990, 32,826 NHS participants provided a blood specimen, which was processed and frozen. Among these women, the follow-up response rate through 1994 was 98%. Self-reported diagnoses of colorectal adenoma on questionnaires were confirmed through histopathologic reports.

To be eligible for selection as a case or control, a woman must have supplied a blood sample, must have subsequently undergone sigmoidoscopy or colonoscopy by 1994, and must not have had a prior cancer or adenoma diagnosis. One control was matched to each case on birth year, month of blood draw, fasting status, year of endoscopy, family history of colorectal cancer, and indication(s) for endoscopy. A total of 249 matched pairs were identified. For 202 of the matched pairs, we previously had assayed plasma concentrations of IGF-I and IGFBP-3 using ELISAs with reagents from Diagnostic Systems Laboratory Inc. (Webster, TX; Ref. 4 ).

The methods for DNA extraction and amplification have been described previously (5) . The oligonucleotide primers used for PCR were: 5′-GCTAGCCAGCTGGTGTTATT-3′ and 5′-ACCACTCTGGGAGAAGGGTA-3′, as described previously (3) . Rapid fragment length detection was performed using the ABI 377 DNA Sequencer (PE Corp.). Representative homozygotes (19/19 and 20/20) were sequenced to confirm (CA)n repeat number. Amplified products were determined relative to Gene Scan-500 size standard using Genescan and Genotyper Analysis software (PE Corp.). Concordance for blinded quality control samples was 100%.

We computed ORs and 95% CIs using conditional logistic regression (SAS version 6.12; SAS Institute, Cary, NC). We compared mean concentrations of plasma IGF-I and IGFBP-3, by genotype. Differences in means were tested using t tests. The study had 80% power (two-sided test; α = 0.05) to detect an OR of 0.59 for all of the other genotypes versus the CA19/29 genotype assuming a CA19/19 prevalence of 0.40.

Results

Frequency of CA alleles did not differ appreciably between cases and controls (Table 1)⇓ . For cases and controls combined, the most common alleles were CA19 (63%) and CA20 (24%). None of the other alleles exceeded a frequency of 5%.

View this table:
  • View inline
  • View popup
Table 1

Frequencies of IGF-I CA repeat alleles in colorectal adenoma cases and controls in the NHS (1989–94)

Comparing the CA19/19 genotype (106 cases and 100 controls) versus all of the other genotypes combined (133 cases and 149 controls), the OR was 1.10 (95% CI, 0.78–1.55) for total colorectal adenomas, 0.90 (95% CI, 0.53–1.52) for large or tubulovillous/villous adenomas, and 1.34 (95% CI, 0.87–2.08) for small/tubular adenomas. Relative to women with the CA19/20 genotype (73 cases and 73 controls), women with genotype CA19/19 (106 cases and 100 controls) did not have a lower adenoma risk (OR = 1.02; 95% CI, 0.67–1.55). None of the other genotypes was related to either an increased or decreased risk of colorectal adenoma relative to the CA19/20 genotype.

In the study by Rosen et al. (3) , men with the CA19/20 genotype appeared to have the highest serum IGF-I concentrations. No significant difference was noted for plasma IGF-I concentrations between women possessing the CA19/19 genotype (mean = 168.6 ng/ml; n = 171) compared with all others (mean = 167.7 ng/ml; n = 233; t test; P = 0.88) or to women with the CA19/20 genotype (166.4 ng/ml; n = 117; P = 0.76). Plasma IGFBP-3 also did not differ by genotype. These results were similar for controls and cases.

Discussion

Unlike a previous study (3) , we did not find lower circulating IGF-I concentrations in individuals with the CA19/19 genotype, despite a 4-fold greater sample size. In addition, total adenoma and large or villous adenoma were not associated with the CA genotype. Our study could not rule out moderate size. However, if this polymorphism acts by influencing circulating IGF-I levels, an important sized effect would be unlikely, because IGF-I concentrations did not vary among the genotypes.

In conclusion, this study does not support the hypothesis that a CA microsatellite region 1-kb upstream from the IGF-I gene is an important predictor of either circulating IGF-I or IGFBP-3 concentrations, or of risk of colorectal adenoma.

Acknowledgments

We thank the participants in the Nurses’ Health Study for their continuing dedication and commitment; and Rachel Meyer, Michele Lachance, Kathryn Starzyk, and Barbara Vericker for expert and unfailing assistance.

Footnotes

  • ↵1 This work was supported by Research Grants CA 40356 and CA 49449 from the NIH, and a grant from the National Cancer Institute of Canada (to M. N. P.).

  • ↵2 To whom requests for reprints should be addressed, at Channing Laboratory, 181 Longwood Avenue, Boston, MA 02115. Phone: (617) 432-4648; Fax: (617) 432-2435; E-mail: edward.giovannucci{at}channing.harvard.edu

  • ↵3 The abbreviations used are: IGF, insulin-like growth factor; IGFBP-3, IGF binding protein-3; IOM, idiopathic osteoporosis; CA, cytosine-adenosine; NHS, Nurses’ Health Study; OR, odds ratio; CI, confidence interval.

  • Received April 18, 2002.
  • Revision received August 2, 2002.
  • Accepted August 19, 2002.

References

  1. ↵
    Rosen C. J., Dimai H. P., Vereault D., Donahue L. R., Beamer W. G., Farley J., Linkhart S., Linkhart T., Mohan S., Baylink D. J. Circulating and skeletal insulin-like growth factor-I (IGF-I) concentrations in two inbred strains of mice with different bone mineral densities. Bone, 21: 217-223, 1997.
    OpenUrlPubMed
  2. ↵
    Kurland E. S., Chan F. K., Rosen C. J., Bilezikian J. P. Normal growth hormone secretory reserve in men with idiopathic osteoporosis and reduced circulating levels of insulin-like growth factor-I. J. Clin. Endocrinol. Metab., 83: 2576-2579, 1998.
    OpenUrlCrossRefPubMed
  3. ↵
    Rosen C. J., Kurland E. S., Vereault D., Adler R. A., Rackoff P. J., Craig W. Y., Witte S., Rogers J., Bilezikian J. P. Association between serum insulin growth factor-I (IGF-I) and a simple sequence repeat in IGF-I gene: implications for genetic studies of bone mineral density. J. Clin. Endocrinol. Metab., 83: 2286-2290, 1998.
    OpenUrlCrossRefPubMed
  4. ↵
    Giovannucci E., Pollak M. N., Platz E. A., Willett W. C., Stampfer M. J., Majeed N., Colditz G. A., Speizer F. E., Hankinson S. E. A prospective study of plasma insulin-like growth factor-I and binding protein-3 and risk of colorectal neoplasia in women. Cancer Epidemiol. Biomark. Prev., 9: 345-349, 2000.
    OpenUrlAbstract/FREE Full Text
  5. ↵
    Missmer S. A., Haiman C. A., Hunter D. J., Willett W. C., Colditz G. A., Speizer F. E., Pollak M. N., Hankinson S. E. A sequence repeat in the insulin-like growth factor-1 gene and risk of breast cancer. Int. J. Cancer, 100: 332-336, 2002.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top
November 2002
Volume 11, Issue 11
  • Table of Contents

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Epidemiology, Biomarkers & Prevention article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Dinucleotide Repeat in the Insulin-like Growth Factor-I Gene Is Not Related to Risk of Colorectal Adenoma
(Your Name) has forwarded a page to you from Cancer Epidemiology, Biomarkers & Prevention
(Your Name) thought you would be interested in this article in Cancer Epidemiology, Biomarkers & Prevention.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Dinucleotide Repeat in the Insulin-like Growth Factor-I Gene Is Not Related to Risk of Colorectal Adenoma
Edward Giovannucci, Christopher A. Haiman, Elizabeth A. Platz, Susan E. Hankinson, Michael N. Pollak and David J. Hunter
Cancer Epidemiol Biomarkers Prev November 1 2002 (11) (11) 1509-1510;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Dinucleotide Repeat in the Insulin-like Growth Factor-I Gene Is Not Related to Risk of Colorectal Adenoma
Edward Giovannucci, Christopher A. Haiman, Elizabeth A. Platz, Susan E. Hankinson, Michael N. Pollak and David J. Hunter
Cancer Epidemiol Biomarkers Prev November 1 2002 (11) (11) 1509-1510;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Diet Quality and Ovarian Cancer Survival
  • PDE5 inhibitors use and precursors of colorectal cancer
  • Association between serum iron biomarkers and breast cancer
Show more Null Results in Brief
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • Online First
  • Current Issue
  • Past Issues

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Epidemiology, Biomarkers & Prevention

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Epidemiology, Biomarkers & Prevention
eISSN: 1538-7755
ISSN: 1055-9965

Advertisement